Cardiology Practice Valuation Benchmarks, 2026

The U.S. cardiology market has undergone a fundamental structural transformation over the past decade. As of 2024, only 30.7% of cardiologists worked in physician-owned practices, down from approximately 74% in 2008. Of the nation’s 33,000 active cardiologists, only an estimated 10,000 remain in independent practice, and nearly 80% of those operate in groups of fewer than 10 physicians. More than 2,500 cardiology group practices are active nationwide, yet fewer than 350 are sizable and independent. By 2022, roughly 90% of cardiology practices were hospital-integrated, leaving only 10% to 12% truly independent.¹

This compression of independent practice has coincided with an unprecedented surge in private equity consolidation, fundamentally reshaping valuation dynamics across the specialty.

What you’ll learn in this article:

Private Equity Activity: The Dominant Valuation Driver

No force has had a greater impact on cardiology practice valuation benchmarks than the accelerating wave of private equity (PE) acquisitions. A landmark study published in the Journal of the American College of Cardiology documented 342 PE acquisitions of outpatient cardiology clinic sites between 2013 and 2023, with over 94% of those transactions occurring between 2021 and 2023 alone.

A complementary cross-sectional analysis published in JAMA Health Forum found that PE-acquired cardiology practices grew from 1 firm with 7 locations in 2019 to 50 firms with 320 locations by the end of 2023, a 45-fold expansion in location count over/under five years.² That momentum has continued: six cardiology practice acquisitions were completed in the first two quarters of 2025 alone, matching the total deal count for all of 2024.³ PE firms are targeting cardiology alongside orthopedics, given their positioning as high-cost-of-care specialties described as “primed to advance adoption of value-based care models.⁴“

By the time of the 2024 MedAxiom survey, nearly 50% of all private practice cardiovascular groups were part of a PE portfolio, up from effectively zero just a few years prior.⁵

EBITDA Multiples: The Primary Valuation Metric

Adjusted EBITDA remains the foundational metric in cardiology practice valuation. Adjusted EBITDA normalizes net income by removing owner-specific or nonrecurring expenses to reveal sustainable cash flow, and valuation is expressed as a multiple of that figure. For cardiology practices in 2025-2026, PE buyers have demonstrated a valuation range of approximately 8.0x to 18.0x Adjusted EBITDA, with positioning within that range determined by scale, provider mix, ancillary infrastructure, and growth trajectory.⁶

Commentary by Fry published in JACC notes that acquired cardiologists have received initial payments of up to $1 million to $2 million per physician at the time of a first-round sale, with additional upside potential at a subsequent recapitalization or secondary sale, typically occurring on a 3- to 10-year cycle.⁷ Many established PE platforms in cardiology are now approaching that second-sale phase, injecting fresh capital to support continued acquisitions.⁴

Physician Productivity Benchmarks

Accurate valuation analysis requires granular provider productivity data. For 2025, cardiologists generated a median of 9,850 work Relative Value Units (wRVUs) annually, placing the specialty among the highest-volume procedural fields in medicine, and the median compensation conversion rate for cardiology was $60.00 per wRVU.⁸ Subspecialty production differentials carry meaningful valuation implications.

According to MedAxiom’s 2024 survey, invasive cardiologists, electrophysiologists, and interventional cardiologists all surpassed $700,000 in median total annual compensation for the first time, driven by high procedural volume and the expanding migration of structural and rhythm procedures to outpatient ambulatory surgical center settings.

Advanced practice providers (APPs) in cardiovascular medicine posted an 8% increase in median wRVUs, reaching 1,987 in 2024, and private practice APPs earned a median of $126,583, slightly outpacing their counterparts in integrated settings.⁵ A growing APP-to-physician ratio can enhance practice-level EBITDA margins and is increasingly cited as a value-enhancing factor in PE due diligence.

Revenue Cycle, Operating Costs, and Reimbursement Pressures

Operating cost pressure is intensifying. Medical practice operating expenses rose an average of approximately 11.1% in 2025 compared to the prior year.⁹ This compounds a severe existing reimbursement headwind: Medicare payments to cardiologists declined approximately 29% in inflation-adjusted terms from 2005 to 2021, while hospital facility reimbursements rose nearly 70% over the same period.¹

In 2025, the Centers for Medicare and Medicaid Services further reduced the Medicare Physician Fee Schedule conversion factor by 2.83%, translating to an average 2.9% cut in physician payments.¹ Specialty societies have described the cumulative effect as “death by a thousand cuts,” underscoring why revenue cycle performance and ancillary diversification have become prerequisites for above-median valuations.

Value Drivers and Strategic Positioning

Beyond financial metrics, buyers assess structural factors that directly influence where a practice lands within the valuation range. Geographic footprint, particularly presence in high-growth Sun Belt markets, has been correlated with elevated PE acquisition probability, as demonstrated by the concentration of deals in Arizona, Florida, and Texas.²

Research published in JACC in 2025 found that hospital-cardiologist integration was associated with modest increases in utilization without corresponding improvements in mortality or readmission rates following myocardial infarction, reinforcing the independent practice model’s appeal to value-focused buyers.⁷

A 2026 commentary in the American Journal of Managed Care emphasized that sustaining independent cardiology requires active investment in benchmarking tools, technology-enabled care delivery, and physician governance structures—the same attributes that position a practice favorably in any ownership transition.¹